Table 2.
Primary and secondary outcomes, and assessment method
| Primary/ secondary | Outcome variable | Assessment method |
|---|---|---|
| Primary |
Uptake of screening |
laboratory database |
| Secondary 1 |
GDM prevalence |
laboratory database |
| Secondary 2 |
Timing of screening |
laboratory database |
| Secondary 3 |
Time to access antenatal diabetes care |
Hospital database |
| Secondary 4 |
Pregnancy outcomes: |
Hospital database |
| Maternal outcomes | ||
| Caesarean section delivery | ||
| Assisted normal delivery | ||
| Hypertension | ||
| Pre-eclampsia texaemia (PET) | ||
| Antepartum haemorrhage (APH) | ||
| Post-partum haemorrhage (PPH) | ||
| Neonatal outcomes: | ||
| Miscarriage | ||
| Foetal death intrauterine (FDIU) | ||
| Stillbirth | ||
| Admission to neonatal intensive care unit (NICU) | ||
| Length of stay at NICU | ||
| Gestational age | ||
| Size for gestational age | ||
| Congenital malformations | ||
| Apgar scores | ||
| Respiratory distress | ||
| Hypoglycemia | ||
| Jaundice | ||
| Composite perinatal score (neonatal hypoglycemia, respiratory distress, need for phototherapy, birth trauma, 5-minute Apgar score less than 7, or prematurity). |